Aspira women's health announces the appointment of mike buhle as svp of commercial operations

Interim cfo john kallassy to depart january 10 austin, tx / accesswire / january 10, 2025 / aspira women's health inc. ("aspira" or the "company") (nasdaq:awh), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced the appointment of mike buhle as svp of commercial operations. mr. buhle has over 25 years of experience driving commercial growth and new product launches in the diagnostics and life science tools domains, working for start-up, scale-up, and established businesses.
AWH Ratings Summary
AWH Quant Ranking